Cargando…
Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors
Chemotherapy is a common treatment for breast cancer (BrCa) and can cause chemotherapy‐induced peripheral neuropathy (CIPN). CIPN contributes to falls, and is thus a potential risk factor for nontraumatic fractures (NTFx); yet, the effect of CIPN on NTFx risk has not been examined for BrCa survivors...
Autores principales: | McNeish, Brendan L., Richardson, James K., Bell, Sarah G., Whitney, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328798/ https://www.ncbi.nlm.nih.gov/pubmed/34368609 http://dx.doi.org/10.1002/jbm4.10519 |
Ejemplares similares
-
Whole-Body Vibration as a Modality for the Rehabilitation of Peripheral Neuropathies: Implications for Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy
por: Verhulst, Anna L.J., et al.
Publicado: (2015) -
Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
por: Kanda, K., et al.
Publicado: (2019) -
Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
por: Trendowski, Matthew R., et al.
Publicado: (2021) -
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Safe administration of chemotherapy in mast cell activation syndrome
por: Lythgoe, MP, et al.
Publicado: (2020)